SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11589270
Source:
http://linkedlifedata.com/resource/pubmed/id/11589270
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0015316
,
umls-concept:C0030705
,
umls-concept:C0117996
,
umls-concept:C0298130
,
umls-concept:C1272689
,
umls-concept:C1707455
pubmed:issue
9
pubmed:dateCreated
2001-10-8
pubmed:abstractText
The prevalence of asthma is increasing, and this chronic condition imposes a substantial economic burden worldwide. It is not known whether newer therapies, such as leukotriene receptor antagonists (LTRAs), can ease this burden.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7706726
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Acetates
,
http://linkedlifedata.com/resource/pubmed/chemical/Androstadienes
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Asthmatic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Quinolines
,
http://linkedlifedata.com/resource/pubmed/chemical/fluticasone
,
http://linkedlifedata.com/resource/pubmed/chemical/montelukast
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0149-2918
pubmed:author
pubmed-author:BuksteinD ADA
,
pubmed-author:HingD NDN
,
pubmed-author:LuskinA TAT
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1589-600
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11589270-Acetates
,
pubmed-meshheading:11589270-Adolescent
,
pubmed-meshheading:11589270-Adult
,
pubmed-meshheading:11589270-Aged
,
pubmed-meshheading:11589270-Aged, 80 and over
,
pubmed-meshheading:11589270-Androstadienes
,
pubmed-meshheading:11589270-Anti-Asthmatic Agents
,
pubmed-meshheading:11589270-Asthma
,
pubmed-meshheading:11589270-Child
,
pubmed-meshheading:11589270-Child, Preschool
,
pubmed-meshheading:11589270-Cohort Studies
,
pubmed-meshheading:11589270-Female
,
pubmed-meshheading:11589270-Health Care Costs
,
pubmed-meshheading:11589270-Humans
,
pubmed-meshheading:11589270-Insurance Claim Review
,
pubmed-meshheading:11589270-Male
,
pubmed-meshheading:11589270-Middle Aged
,
pubmed-meshheading:11589270-Patient Compliance
,
pubmed-meshheading:11589270-Quinolines
,
pubmed-meshheading:11589270-Respiratory Function Tests
,
pubmed-meshheading:11589270-Retrospective Studies
,
pubmed-meshheading:11589270-Treatment Outcome
pubmed:year
2001
pubmed:articleTitle
A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy.
pubmed:affiliation
Dean Foundation for Health, Research, and Education, Dean Medical Center, Madison, Wisconsin 53590, USA.
pubmed:publicationType
Journal Article
,
Comparative Study
,
Research Support, Non-U.S. Gov't